Targeted Gene Therapy for Ischemic Stroke - Gene Delivery and Therapy for Neurological Disorders - page 200

References

1. Greenberg DA, Jin K (2005) From angiogen-
esis to neuropathology. Nature 438:954-959
2. Simons M, Ware JA (2003) Therapeutic angio-
genesis in cardiovascular disease. Nat Rev
Drug Discov 2:863-871
3. Wei L, Cui L, Snider BJ et al (2005)
Transplantation of embryonic stem cells over-
expressing Bcl-2 promotes functional recovery
after transient cerebral ischemia. Neurobiol
Dis 19:183-193
4. Shen F, Fan Y, Su H et al (2008) Adeno-
associated viral vector-mediated hypoxia-
regulated VEGF factor gene transfer promotes
angiogenesis following focal cerebral ischemia
in mice. Gene Ther 15:30-39
5. Shen F, Walker EJ, Jiang L et al (2011)
Coexpression of angiopoietin1 with VEGF
increases the structural integrity of the blood-
brain barrier and reduces atrophy volume.
J Cereb Blood Flow Metab 31:2343-2351
6. Zeng L, He X, Wang Y et al (2014)
MicroRNA-210 overexpression induces angio-
genesis and neurogenesis in the normal adult
mouse brain. Gene Ther 21:37-43
7. An S, Kuang Y, Shen T et al (2013) Brain-
targeting delivery for RNAi neuroprotection
against cerebral ischemia reperfusion injury.
Biomaterials 34:8949-8959
8. Tang Y, Li Y, Lin X et al (2014) Stimulation of
cerebral angiogenesis by gene delivery.
Methods Mol Biol 1135:317-329
9. Springer ML, Chen AS, Kraft PE et al (1998)
VEGF gene delivery to muscle: potential role for
vasculogenesis in adults. Mol Cell 2:549-558
10. Lee RJ, Springer ML, Blanco-Bose WE et al
(2000) VEGF gene delivery to myocardium:
deleterious effects of unregulated expression.
Circulation 102:898-901
11. Schwarz ER, Speakman MT, Patterson M et al
(2000) Evaluation of the effects of intramyo-
cardial injection of DNA expressing vascular
endothelial growth factor (VEGF) in a myo-
cardial infarction model in the rat—angiogen-
esis and angioma formation. J Am Coll Cardiol
35:1323-1330
12. Bohl D, Salvetti A, Moullier P et al (1998)
Control of erythropoietin delivery by
doxycycline in mice after intramuscular injec-
tion of adeno-associated vector. Blood 92:
1512-1517
13. Hofmann A, Nolan GP, Blau HM (1996) Rapid
retroviral delivery of tetracycline-inducible genes
in a single autoregulatory cassette. Proc Natl
Acad Sci U S A 93:5185-5190
14. Bohl D, Naffakh N, Heard JM (1997) Long-
term control of erythropoietin secretion by

doxycycline in mice transplanted with engi-
neered primary myoblasts. Nat Med 3:299-305
15. Gossen M, Bujard H (1992) Tight control of
gene expression in mammalian cells by
tetracycline-responsive promoters. Proc Natl
Acad Sci U S A 89:5547-5551
16. Wang Y, O'Malley BW Jr, Tsai SY et al (1994)
A regulatory system for use in gene transfer.
Proc Natl Acad Sci U S A 91:8180-8184
17. Blau HM, Rossi FM (1999) Tet B or not tet B:
advances in tetracycline-inducible gene expres-
sion. Proc Natl Acad Sci U S A 96:797-799
18. Rossi FM, Guicherit OM, Spicher A et al (1998)
Tetracycline-regulatable factors with distinct
dimerization domains allow reversible growth
inhibition by p16. Nat Genet 20:389-393
19. Kringstein AM, Rossi FM, Hofmann A et al
(1998) Graded transcriptional response to dif-
ferent concentrations of a single transactivator.
Proc Natl Acad Sci U S A 95:13670-13675
20. Vanrell L, Di Scala M, Blanco L et al (2011)
Development of a liver-specifi c Tet-on induc-
ible system for AAV vectors and its application
in the treatment of liver cancer. Mol Ther
19:1245-1253
21. Wang GL, Jiang BH, Rue EA et al (1995)
Hypoxia-inducible factor 1 is a basic-helix-
loop-helix-PAS heterodimer regulated by cel-
lular O 2 tension. Proc Natl Acad Sci U S A
92:5510-5514
22. Wang GL, Semenza GL (1995) Purifi cation
and characterization of hypoxia-inducible fac-
tor 1. J Biol Chem 270:1230-1237
23. Huang LE, Gu J, Schau M et al (1998)
Regulation of hypoxia-inducible factor 1alpha
is mediated by an O 2 -dependent degradation
domain via the ubiquitin-proteasome pathway.
Proc Natl Acad Sci U S A 95:7987-7992
24. Jiang BH, Rue E, Wang GL et al (1996)
Dimerization, DNA binding, and transactiva-
tion properties of hypoxia-inducible factor 1. J
Biol Chem 271:17771-17778
25. Shen F, Su H, Liu W et al (2006) Recombinant
adeno-associated viral vector encoding human
VEGF165 induces neomicrovessel formation
in the adult mouse brain. Front Biosci 11:
3190-3198
26. Su H, Arakawa-Hoyt J, Kan YW (2002)
Adeno-associated viral vector-mediated
hypoxia response element-regulated gene
expression in mouse ischemic heart model.
Proc Natl Acad Sci U S A 99:9480-9485
27. Kaplitt MG, Leone P, Samulski RJ et al (1994)
Long-term gene expression and phenotypic
correction using adeno-associated virus vectors
in the mammalian brain. Nat Genet 8:148-154